Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription

  title={Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription},
  author={Yongfeng Shang and Xiao Hu and James Direnzo and Mitchell A. Lazar and Myles A Brown},

Figures from this paper

The estrogen receptor: more than the average transcription factor.

The human estrogen receptor is a steroid nuclear receptor found in breast cancer and a variety of other tissues and is responsible for the transcriptional regulation of estrogen-responsive genes through recruitment of coactivators and corepressors of transcription.

Estrogen-receptor-α exchange and chromatin dynamics are ligand- and domain-dependent

Quantitative observations from this physiologically relevant biosensor suggest stochastic-based dynamics influence gene regulation at the promoter level.

Transcriptional Coactivators and Corepressors in Endocrine Response and Resistance in Breast Cancer

These studies have highlighted coactivator and corepressor proteins that appear to be critical for the agonist and antagonist actions of estrogen and anti-estrogens, and indicate that altered levels and/or activities of these proteins is an important feature of response and resistance to endocrine treatments in breast cancer.

Activation of Estrogen Receptor-α by E2 or EGF Induces Temporally Distinct Patterns of Large-Scale Chromatin Modification and mRNA Transcription

This work shows that there is a stimuli-specific pattern of large-scale chromatin modification and transcript levels by ER, and differential recruitment of GFP-ER to the array, with the AF1 domain playing a vital role in EGF-mediated responsiveness.

Cytidine Deaminases are Regulators of Estrogen Receptor Activity in Breast Cancer Cells

ZNF366 acts as a corepressor by interacting with other known ERa corepressors, namely RIP140 and CtBP, to inhibit expression of estrogen-responsive genes in vivo and indicates that ZNF366 may play an important role in regulating the expression of genes in response to estrogen.

Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor.

In vivo work defines the first corepressor of nuclear receptors that modulates ERalpha-dependent gene expression by stalling RNAPII, and suggests that this new level of regulation may be important to control the duration and magnitude of a rapid and reversible hormonal response.

Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells

It is shown that specific silencing of TLE1 inhibits the ability of ER to bind to a subset of ER binding sites within the genome, a phenomenon that results in perturbations in phospho-RNA Pol II recruitment.

Differential recruitment of nuclear receptor coregulators in ligand-dependent transcriptional repression by estrogen receptor-α

Results from these studies indicate that nuclear receptor corepressor recruitment is a key feature of ligand-dependent transcriptional repression by Ers, and some repressed target genes are associated with disease progression and response to endocrine therapy.

Sufficiency analysis of estrogen responsive enhancers using synthetic activators

Test the sufficiency of promoter-distal estrogen receptor α-binding sites (ERBSs) for activating gene expression by recruiting synthetic activators in the absence of estrogens and found that ERBSs work independently to control gene expression when bound by syntheticactivators.



Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription.

Evidence suggests that ERAP160 may mediate estradiol-dependent transcriptional activation by the estrogen receptor, and the ability of antiestrogens to block estrogen receptor-ERAP160 complex formation could account for their therapeutic effects in breast cancer.

p300 is a component of an estrogen receptor coactivator complex.

It is found that the transcriptional coactivator p300 associates with agonist bound ER and augments ligand-dependent activation by ER, suggesting p300 functions as a point of integration between ER and these other pathways.

AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor

The ability of growth factors to modulate estrogen action may be mediated through MAPK activation of the nuclear receptor coactivator AIB1, which is demonstrated to be a phosphoprotein in vivo and can be phosphorylated in vitro by MAPK.

Mechanism of estrogen activation of c-myc oncogene expression.

A new mechanism of estrogen trans-activation in the c-myc gene promoter is proposed, which shows that the DNA-binding domain of the receptor is essential for estrogen-regulated CAT gene expression.

Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex.

  • J. FondellH. GeR. Roeder
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 1996
These findings demonstrate the ligand-dependent in vivo formation of a transcriptionally active TR-multisubunit protein complex and suggest a role for TRAPs as positive coactivators for gene-specific transcriptional activation.

p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation.

ER exhibits distinct, dual functions in transcription initiation and reinitiation, suggesting a two-stroke mechanism for transcriptional activation by ligand-activated ER and p300.

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes.

The data suggest that N-CoR- and SMRT-containing complexes act as rate-limiting components in the actions of specific nuclear receptors, and that their actions are regulated by multiple signal transduction pathways.

Mechanism of corepressor binding and release from nuclear hormone receptors.

The identity of complementary acting signature motifs in SMRT and N-CoR that are sufficient for receptor binding and ligand-induced release are reported and indicate a direct mechanistic link between activation and repression via competition for a common or at least partially overlapping binding site.

Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily

Results indicate that SRC-1 encodes a coactivator that is required for full transcriptional activity of the steroid receptor superfamily.

Role of CBP/P300 in nuclear receptor signalling

In vitro and in vivo evidence is provided that identifies the CREB-binding protein (CBP) and its homologue P300 as cofactors mediating nuclear-receptor-activated gene transcription and may serve as integrators of extracellular and intracellular signalling pathways.